Abstract:Molecular engineering for multifunctional fluorophores (namely BTA and BTB) is presented based on a characteristic electron donor‐π‐acceptor architecture. BTA emits bright near‐infrared II fluorescence and demonstrates remarkable mitochondria‐targeting features and exceptional phototherapy properties to suppress cancer cells both in vitro and in vivo. Importantly, the molecular mechanisms of the phototherapies are elucidated by inducing synergistic cell apoptosis and pyroptosis. Conventional photosensitizers for tumor phototherapy are greatly limited by their reliance on a single‐cell death process, leading to insufficient therapeutic effects and restricted biomedical applications. To address these limitations, multifunctional fluorophores, BTA and BTB, are designed based on an electron donor‐π‐acceptor system. By adjusting the strength of the intramolecular charge transfer through varying electron‐donating moieties, their optical properties are tailored. BTA emits bright near‐infrared II (NIR‐II) fluorescence and exhibits typical aggregation‐induced emission (AIE) characteristics, a large Stokes shift (>250 nm), good photostability, satisfactory biocompatibility, and remarkable mitochondria‐targeting capabilities. Notably, it demonstrates potent photodynamic and photothermal properties. BTA as an effective photosensitizer and a photothermal agent, generates various cytotoxic Type I and II reactive oxygen species and photothermal energy to effectively destroy tumor cell mitochondria and suppress tumor growth. Importantly, the molecular mechanisms underlying combination phototherapy are elucidated, revealing that it induces synergistic cell apoptosis and pyroptosis. These results highlight the potential of multifunctional AIE materials with bright NIR‐II fluorescence and mitochondria‐targeting characteristics for the synergistic phototherapy of breast tumors, offering new insights for future therapeutic developments.

Synergetic Pyroptosis with Apoptosis Improving Phototherapy of Mitochondria-Targeted Cyanines with Superior Photostability

A Mitochondria‐Targeted Photosensitizer for Combined Pyroptosis and Apoptosis with NIR‐II Fluorescence/Photoacoustic Imaging‐Guided Phototherapy

Molecular Engineering of Plasma Membrane and Mitochondria Dual‐Targeted NIR‐II AIE Photosensitizer Evoking Synergetic Pyroptosis and Apoptosis

Mitochondria Targeting Photoredox Catalyst-Induced Pyroptosis for Enhanced Immunotherapy Against Hypoxic Tumor Cells

Endoplasmic reticulum and mitochondrial double-targeted NIR photosensitizer synergistically promote tumor cell death

Near‐Infrared II AIE Luminogens with Mitochondria‐Targeting Characteristics for Combinational Phototherapies of Breast Tumors Through Synergistic Cell Apoptosis and Pyroptosis

Mitochondria Targeted Nanoparticles Potentiate Tumor Chemo-Phototherapy by Toxic Oxidative Stress Mediated Oxeiptosis

Boosting the Photodynamic Therapy Efficiency with a Mitochondria-Targeted Nanophotosensitizer

Efficient NIR-II Type-I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy through Synergistic Apoptosis-Ferroptosis

Enhanced porphyrin-based fluorescence imaging-guided photodynamic/photothermal synergistic cancer therapy by mitochondrial targeting

Pyroptosis Activation by Photodynamic-Boosted Nanocatalytic Medicine Favors Malignancy Recession

Biomimetic Nano‐Photosensitizer Amplifies Immunogenic Pyroptosis and Triggers Synergistic Cancer Therapy

Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy.

Inspired heat shock protein alleviating prodrug enforces immunogenic photodynamic therapy by eliciting pyroptosis

A pyroptosis nanotuner for cancer therapy

A Photothermal-Hypoxia Sequentially Activatable Phase-Change Nanoagent for Mitochondria-Targeting Tumor Synergistic Therapy

Enhanced photodynamic therapy through multienzyme-like MOF for cancer treatment

Pyroptosis‐Mediated Synergistic Photodynamic and Photothermal Immunotherapy Enabled by a Tumor‐Membrane‐Targeted Photosensitive Dimer (Adv. Mater. 25/2023)

Devising Biocompatible, NIR-Activated Helical Pyroptosis Agents via 𝛑-Twisting Strategy for Promoting Antitumor Immunity

A Mitochondria‐Targeted NIR‐II AIEgen Induced Pyroptosis for Enhanced Tumor Immunotherapy

Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy